Targeted OncologyStudy Identifies Subset of NSCLC Patients Who Experience Hyperprogression After ImmunotherapyTargeted OncologyA multicenter retrospective analysis presented at the 2017 ESMO Congress found that a newly defined subset of patients treate… Continue reading
|
Brammer Bio Completes Expansion Of Cell And Gene Therapy Clinical Manufacturing Facilities In Florida
Pharmaceutical Online (press release) Cambridge, MA /PRNewswire/ – Brammer Bio (“Brammer”), a cell and gene therapy contract development and manufacturing organization (CDMO), today announced completion of its clinical capacity expansion in Alachua, Florida. This doubles Brammer’s … |
Hindustan Times |
Immunotherapy: How your immune system can be roped in to treat breast cancer
Hindustan Times At the World Cancer Congress in Chicago, USA, in June, a team from France’s Institut Gustave Roussy in Villejuif, on the outskirts of Paris, presented a new immunotherapy treatment called nivomulab, aimed at treating so-called “female” cancers such as … |